Generalized Pustular News Today : Breaking News, Live Updates & Top Stories | Vimarsana

1. Efficacy of spesolimab appeared to be dose-dependent with high-dose spesolimab leading to a significantly longer time to GPP flare-up versus placebo. 2. There were no treatment-related deaths or hypersensitivity reactions across groups. Evidence Rating Level: 1 (Excellent) Study Rundown: Generalized pustular psoriasis (GPP) is a rare but chronic skin condition with a high morbidity.

上海2023年6月30日 /美通社/ -- 6月29日 ，中国国家药品监督管理局（NMPA）药品审评中心（CDE）正式授予勃林格殷格翰罕见皮肤病创新靶向生物制剂圣利卓® （通用名：佩索利单抗注射液）用......

Experts discuss some rare dermatological disorders that critical care physicians may see in the emergency room setting or dermatologists may see in their clinics along with the prevalence of these diseases.

Mount Sinai researcher shows novel drug significantly improves signs and symptoms of generalized pustular psoriasis—a rare and life-threatening